POST SUMMARY: The model for pharma growth seems to be to merge or buy smaller biotech companies, but is this a viable business decision?
Category Archive: Bad practices
If you want an example of just how far pharma is lagging in digital look no further than the Novartis Oncology lung cancer site.
One of the questions I get asked and asked again is “why haven’t most pharma companies changes in their approach to DTC and digital marketing?”. The answer to this is complex, but at its heart most major consulting research has indicated that time and time again pharma is a laggard when it comes to change and hiring people who can really question current thinking when it comes to meeting the needs of consumers of healthcare.